Improved method for the preparation of a human cell-based, contact model of the blood-brain barrier.

The blood-brain barrier (BBB) comprises impermeable but adaptable brain capillaries which tightly control the brain environment. Failure of the BBB has been implied in the etiology of many brain pathologies, creating a need for development of human in vitro BBB models to assist in clinically-relevant research. Among the numerous BBB models thus far described, a static (without flow), contact BBB model, where astrocytes and brain endothelial cells (BECs) are cocultured on the opposite sides of a porous membrane, emerged as a simplified yet authentic system to simulate the BBB with high throughput screening capacity. Nevertheless the generation of such model presents few technical challenges. Here, we describe a protocol for preparation of a contact human BBB model utilizing a novel combination of primary human BECs and immortalized human astrocytes. Specifically, we detail an innovative method for cell-seeding on inverted inserts as well as specify insert staining techniques and exemplify how we use our model for BBB-related research.

[1]  H. Galla,et al.  Control of the Blood–Brain Barrier by Glucocorticoids and the Cells of the Neurovascular Unit , 2009, Annals of the New York Academy of Sciences.

[2]  J. Berman,et al.  Human fetal astrocytes induce the expression of blood-brain barrier specific proteins by autologous endothelial cells , 1993, Brain Research.

[3]  B. Engelhardt,et al.  The blood–brain and the blood–cerebrospinal fluid barriers: function and dysfunction , 2009, Seminars in Immunopathology.

[4]  G. Donnan,et al.  Human In Vitro Models of Ischaemic Stroke: a Test Bed for Translation , 2012, Translational Stroke Research.

[5]  T. Dalkara,et al.  Brain microvascular pericytes in health and disease , 2011, Acta Neuropathologica.

[6]  R. Medcalf,et al.  t-PA-specific modulation of a human blood-brain barrier model involves plasmin-mediated activation of the Rho kinase pathway in astrocytes. , 2012, Blood.

[7]  T. Davis,et al.  The Blood-Brain Barrier/Neurovascular Unit in Health and Disease , 2005, Pharmacological Reviews.

[8]  D. Vivien,et al.  Impact of Tissue Plasminogen Activator on the Neurovascular Unit: From Clinical Data to Experimental Evidence , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[9]  G. Donnan,et al.  How to make better use of thrombolytic therapy in acute ischemic stroke , 2011, Nature Reviews Neurology.

[10]  E. Hansson,et al.  Astrocyte–endothelial interactions at the blood–brain barrier , 2006, Nature Reviews Neuroscience.

[11]  K. Furie,et al.  Mechanisms of Hemorrhagic Transformation After Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke , 2004, Stroke.

[12]  Barclay Morrison,et al.  Permeability of Endothelial and Astrocyte Cocultures: In Vitro Blood–Brain Barrier Models for Drug Delivery Studies , 2010, Annals of Biomedical Engineering.

[13]  William Shain,et al.  An endothelial and astrocyte co-culture model of the blood-brain barrier utilizing an ultra-thin, nanofabricated silicon nitride membrane. , 2005, Lab on a chip.

[14]  Masami Niwa,et al.  Permeability Studies on In Vitro Blood–Brain Barrier Models: Physiology, Pathology, and Pharmacology , 2005, Cellular and Molecular Neurobiology.

[15]  Edward J. Rapp,et al.  Immortalized Human Brain Endothelial Cells and Flow-Based Vascular Modeling: A Marriage of Convenience for Rational Neurovascular Studies , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[16]  J. Tillement,et al.  Drug Transfer Across the Blood‐Brain Barrier: Correlation Between In Vitro and In Vivo Models , 1992 .

[17]  D. Liebeskind,et al.  Reversing Stroke in the 2010s Lessons From Desmoteplase In Acute ischemic Stroke-2 (DIAS-2) CT and MRI approaches , 2009 .

[18]  C. Iadecola,et al.  Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease. , 2006, Journal of applied physiology.

[19]  N. Nighoghossian,et al.  Intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: an update , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[20]  B. Zlokovic.  The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders , 2008, Neuron.

[21]  Hanseup Kim,et al.  Characterization of a microfluidic in vitro model of the blood-brain barrier (μBBB). , 2012, Lab on a chip.

[22]  V. Teichberg,et al.  Closing the gap between the in-vivo and in-vitro blood–brain barrier tightness , 2009, Brain Research.

[23]  K. Arai,et al.  Lipoprotein receptor–mediated induction of matrix metalloproteinase by tissue plasminogen activator , 2003, Nature Medicine.

[24]  Ulf Eriksson,et al.  Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke , 2008, Nature Medicine.

[25]  J. Pachter,et al.  Culture of murine brain microvascular endothelial cells that maintain expression and cytoskeletal association of tight junction-associated proteins , 2003, In Vitro Cellular & Developmental Biology - Animal.

[26]  R. Janzer,et al.  Astrocytes induce blood–brain barrier properties in endothelial cells , 1987, Nature.

[27]  C. Remacle,et al.  Compartmentalized coculture of rat brain endothelial cells and astrocytes: a syngenic model to study the blood–brain barrier , 2002, Journal of Neuroscience Methods.

[28]  C. Ringbom,et al.  Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[29]  Anwar Rayan,et al.  Blood–brain barrier permeability and tPA-mediated neurotoxicity , 2010, Neuropharmacology.

[30]  E. Major,et al.  Establishment of a line of human fetal glial cells that supports JC virus multiplication. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[31]  B. Engelhardt,et al.  Comparison of Immortalized bEnd5 and Primary Mouse Brain Microvascular Endothelial Cells as in vitro Blood–Brain Barrier Models for the Study of T Cell Extravasation , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[32]  M. Deli,et al.  N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine increases the permeability of primary mouse cerebral endothelial cell monolayers , 2003, Inflammation Research.

[33]  M. Wiley,et al.  Developing nervous tissue induces formation of blood-brain barrier characteristics in invading endothelial cells: a study using quail--chick transplantation chimeras. , 1981, Developmental biology.

[34]  D. Lawrence,et al.  Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. , 2003, The Journal of clinical investigation.

[35]  K. Garber.  Stroke treatment—light at the end of the tunnel? , 2007, Nature Biotechnology.

[36]  J. Berman,et al.  Chemokine-dependent mechanisms of leukocyte trafficking across a model of the blood-brain barrier. , 2003, Methods.

[37]  G. Ford,et al.  Pharmacokinetics of alteplase in the treatment of ischaemic stroke , 2012, Expert opinion on drug metabolism & toxicology.

[38]  L. Fenart,et al.  Mouse syngenic in vitro blood–brain barrier model: a new tool to examine inflammatory events in cerebral endothelium , 2005, Laboratory Investigation.

[39]  J. Greenwood,et al.  Blood‐brain barrier‐specific properties of a human adult brain endothelial cell line , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[40]  David J. Begley,et al.  Structure and function of the blood–brain barrier , 2010, Neurobiology of Disease.

[41]  R. Medcalf,et al.  Thrombin-induced activation of astrocytes in mixed rat hippocampal cultures is inhibited by soluble thrombomodulin , 2011, Brain Research.